The current stock price of QSI is 1.41 USD. In the past month the price decreased by -30.54%. In the past year, price increased by 12.8%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 26.38 | 223.10B | ||
| DHR | DANAHER CORP | 29.41 | 162.39B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 186.73 | 56.66B | ||
| A | AGILENT TECHNOLOGIES INC | 27.51 | 43.52B | ||
| IQV | IQVIA HOLDINGS INC | 19.78 | 39.10B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 35.29 | 30.42B | ||
| WAT | WATERS CORP | 31.77 | 24.01B | ||
| ILMN | ILLUMINA INC | 30.15 | 20.20B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 39.21 | 19.94B | ||
| MEDP | MEDPACE HOLDINGS INC | 41.43 | 16.69B | ||
| TEM | TEMPUS AI INC | N/A | 13.54B | ||
| RVTY | REVVITY INC | 21.8 | 12.12B |
Quantum-Si, Inc. is a life sciences company focused on revolutionizing the growing field of proteomics. The company is headquartered in Branford, Connecticut and currently employs 143 full-time employees. The company went IPO on 2020-09-04. The firm has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. The company has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.
QUANTUM-SI INC
29 Business Park Drive
Branford CONNECTICUT US
CEO: Kevin Rakin
Employees: 149
Phone: 12034587100
Quantum-Si, Inc. is a life sciences company focused on revolutionizing the growing field of proteomics. The company is headquartered in Branford, Connecticut and currently employs 143 full-time employees. The company went IPO on 2020-09-04. The firm has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. The company has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.
The current stock price of QSI is 1.41 USD. The price increased by 4.44% in the last trading session.
QSI does not pay a dividend.
QSI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
QSI stock is listed on the Nasdaq exchange.
7 analysts have analysed QSI and the average price target is 2.89 USD. This implies a price increase of 104.96% is expected in the next year compared to the current price of 1.41.
You can find the ownership structure of QUANTUM-SI INC (QSI) on the Ownership tab.
ChartMill assigns a technical rating of 2 / 10 to QSI. When comparing the yearly performance of all stocks, QSI is one of the better performing stocks in the market, outperforming 84.45% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to QSI. QSI has a great financial health rating, but its profitability evaluates not so good.
Over the last trailing twelve months QSI reported a non-GAAP Earnings per Share(EPS) of -0.67. The EPS decreased by -4.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -44.92% | ||
| ROE | -49.69% | ||
| Debt/Equity | 0 |
7 analysts have analysed QSI and the average price target is 2.89 USD. This implies a price increase of 104.96% is expected in the next year compared to the current price of 1.41.
For the next year, analysts expect an EPS growth of 21.76% and a revenue growth -5.95% for QSI